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Abstract
Background: Results of associations between process and mortality indicators, both used for the external assessment of
hospital care quality or public reporting, differ strongly across studies. However, most of those studies were conducted in
North America or United Kingdom. Providing new evidence based on French data could fuel the international debate
on quality of care indicators and help inform French policy-makers. The objective of our study was to explore whether
optimal care delivery in French hospitals as assessed by their Hospital Process Indicators (HPIs) is associated with low
Hospital Standardized Mortality Ratios (HSMRs).
Methods: The French National Authority for Health (HAS) routinely collects for each hospital located in France, a set
of mandatory HPIs. Five HPIs were selected among the process indicators collected by the HAS in 2009. They were
measured using random samples of 60 to 80 medical records from inpatients admitted between January 1st, 2009 and
December 31, 2009 in respect with some selection criteria. HSMRs were estimated at 30, 60 and 90 days post-admission
(dpa) using administrative health data extracted from the national health insurance information system (SNIIR-AM) which
covers 77% of the French population. Associations between HPIs and HSMRs were assessed by Poisson regression
models corrected for measurement errors with a simulation-extrapolation (SIMEX) method.
Results: Most associations studied were not statistically significant. Only two process indicators were found associated
with HSMRs. Completeness and quality of anesthetic records was negatively associated with 30 dpa HSMR
(0.72 [0.52–0.99]). Early detection of nutritional disorders was negatively associated with all HSMRs: 30 dpa HSMR
(0.71 [0.54–0.95]), 60 dpa HSMR (0.51 [0.39–0.67]) and 90 dpa HSMR (0.52 [0.40–0.68]).
Conclusion: In absence of gold standard of quality of care measurement, the limited number of associations
suggested to drive in-depth improvements in order to better determine associations between process and
mortality indicators. A smart utilization of both process and outcomes indicators is mandatory to capture aspects
of the hospital quality of care complexity.
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Background
In recent decades, measuring quality of care in hospitals
has become a major challenge for many countries.
Indeed, measuring is crucial for assessing and improving
internal quality, informing health policies and justifying
patients’ choices. It is also requested by payers for per-
formance assessment and value-based purchasing [1].
Three types of measures are commonly used to assess
the quality of care in hospitals: structural, process and
outcome indicators [2–5]. Structural measures relate to
the characteristics of the health-care setting [3] such as
the number of units and equipment, number and qualifi-
cations of medical and nursing staff, etc. Assessing an
association between structural measures and both out-
comes and process indicators may sometimes be very
tricky. Indeed, increasing health resources does not
necessarily lead either to a reduction in mortality or an
improvement in processes [5]. Process indicators (PIs)
aim to assess the quality of clinical processes and answer
the following question: do patients receive the best care
possible according to current knowledge? This implies
that achieving the best care processes leads to better
health [6]. Thus, PIs have to be strongly associated with
related health outcomes to be used for quality assess-
ment. Apart from this requirement, PIs present many
advantages and are commonly used in quality improve-
ment, public reporting (e.g. Hospital Inpatient Quality
Reporting Program in the United States or the Canadian
Institute for Health Information’s hospital performance
program), or pay-for-performance (e.g. Medicare Hospital
Quality Alliance Program [7]) programs [8]. Furthermore,
they may be used for hospital accreditation [9, 10]. Out-
come measures of hospital care quality generally refer to
patient health status as a result of health-care processes or
to patient experience with hospital care. Among outcome
indicators, mortality rates are the most widespread mea-
sures. They answer the question about inpatients’ survival
or death during a fixed or variable period of time. Indeed,
mortality is typically the type of information that the
public and patients are interested in [3, 5]. It is easily
measurable, understandable to everyone, and supposedly
cheaper to produce than other types of indicators since it
is regularly collected in countries with health information
systems. Moreover, it is frequently used for comparing
performance between hospitals [11]. However, like other
outcome indicators, mortality rates depend on various
factors including patient case-mix [12] (i.e. patient
characteristics, comorbidity and severity at admission)
and data accuracy [13], which could be confounding
factors for measuring quality of care. Hence, they have
to be accurately measured and adjusted on case-mix
before comparing mortality across providers or being
used for hospital profiling. Owing to the above men-
tioned limitations, they act as signals or flags to identify
structures where further investigations have to be con-
ducted [13].
Many studies aiming to assess the relationship be-
tween process and mortality indicators have been con-
ducted mainly on US and UK data [7, 11, 14–17].
Various statistical methods have been used to assess this
relationship ranging from simple correlations to hier-
archical models. The underlying hypothesis is that hospi-
tals with high mortality rates are very likely to have poor
PI results [8]. However, some studies have failed to show
this association. A systematic review published in 2007
[17] which included 36 studies examining 51 relation-
ships between PIs and risk-adjusted mortality found a
positive correlation in only half of the relationships
(51%). There was no association between the two types
of indicators in 31% of the relationships and paradoxical
associations in 18%. The authors concluded that there is
neither consistency nor reliability to assert that high
risk-adjusted mortality is related to poor quality of care
in hospitals. In this context, providing new evidence based
on French data would be of significant interest [18–20].
Moreover, our study should fuel the quality-of-care debate
in France and help inform French policy-makers’ decision
regarding the inclusion of quality indicators into quality
improvement, public reporting, pay-for-performance and
accreditation programs.
The objective of our study was to explore whether op-
timal care delivery in French hospitals as assessed by
their PIs was associated with low HSMRs measured for
different conditions and timeframes.
Methods
Hospital Process Indicators (HPIs)
Since 2008, French hospitals have been subjected to an
annual collection of mandatory indicators. These indica-
tors have been progressively integrated in the National
Quality Improvement Framework driven by the French
National Authority for Health (Haute Autorité de Santé,
HAS) and including public reporting, hospital accredit-
ation and pay-for-performance.
In 2009, the HAS collected 13 mandatory HPIs
designed to evaluate four components of hospital care
processes: 1) Inpatient medical records; 2) Anesthesia
records; 3) Multidisciplinary team meetings in oncology;
4) In-hospital care for myocardial infarction. In our
study, we selected 5 HPIs among the 13 that focused on
three priority areas: continuity of care, early detection of
nutritional disorders, and adherence to best practice
guidelines. Those 5 indicators were a priori selected
based on both the public availability of their results and
their recording for all patients.
HPI1 (“Early Detection of Nutritional Disorder level 1”)
estimates, for each hospital, the proportion of adult inpa-
tients (≥18 years at admission) hospitalized in acute care
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during the year for whom weight is recorded in medical
or nursing notes within 2 days of admission [21]. Weight
measurement is a pre-requisite for the successful preven-
tion of nutritional disorders.
HPI2 (“Beta-blocker, Antiplatelet agent, Statin and
ACE Inhibitor prescription at discharge in the treatment
of acute myocardial infarction”, BASI score) [22] evalu-
ates the appropriate prescription at discharge of four
medications recommended for the treatment of inpa-
tients with acute myocardial infarction. It estimates, for
each hospital, the proportion of adult inpatients admit-
ted during the year for an acute myocardial infarction
and who were prescribed four medications at discharge
according to the French professional guidelines.
HPI3 (“Multidisciplinary Team (MDT) Meetings in
Oncology”) estimates, for each hospital, the proportion
of inpatients of all ages at admission, hospitalized for
an initial cancer treatment during the year, and for
whom a MDT meeting is recorded in their medical
notes. MDT meetings have become mandatory since
2007 in France and must be mentioned in the patient’s
medical records [23].
HPI4 (“Completeness and Quality of Anesthetic
Records”) [21] assesses the appropriate reporting of
anesthetic information in inpatient medical records. Re-
quired information in medical records is audited using 13
criteria (if applicable) including six for the pre-anesthetic
period, two for the per-anesthetic period, three for the
post-anesthetic period, and one encompassing the three
periods. For each acute care hospital, individual propor-
tions of fulfilled criteria among the 13 (if applicable) are
calculated for randomly selected inpatients of any age,
who underwent general or regional anesthesia during a
surgical procedure. HPI4 is then calculated as the average
of individual proportions among randomly selected inpa-
tients during the year of interest. Appropriate reporting of
anesthetic information contributes to care coordination
and anesthetic risk control in patients admitted to
surgical units.
HPI5 (“Completeness and Quality of Medical Records”)
assesses the appropriate reporting of ten items in inpa-
tients’ medical notes [23]. It is the most important indica-
tor for assessing care coordination. Indeed, medical
records are the main tool for sharing patient information
and ensuring continuity of care. Required information in
medical records is audited using the ten criteria (if applic-
able). For each acute care hospital, individual proportions
of fulfilled criteria among the ten (if applicable) are
calculated for randomly selected inpatients of any age hos-
pitalized in acute care. HPI5 is then calculated as the aver-
age of individual proportions among randomly selected
inpatients during the year of interest.
HPIs were estimated for each hospital by auditing
samples of inpatient medical records randomly selected
between January 1st, 2009 and December 31st, 2009.
Medical records were selected according to inclusion
and exclusion criteria specific to each HPI denominator,
as defined by HAS expert groups (see selection criteria in
Additional file 1). HAS experts determined the acceptable
sample size needed to estimate each HPI: 60 for HPI2,
HPI3 and HPI4 and 80 for HPI1 and HPI5 [24, 25]. This
choice of 60 to 80 records resulted from a trade-off
between indicator precision or statistical power in
between-hospital comparisons, and the workload gener-
ated by this data collection within each hospital [24].
Hospital Outcome Indicators (HOIs)
In 2010, the “Post-Hospital Mortality Analysis, aiming at
estimating Indicators” project (AMPHI) was conducted
in France to assess the feasibility of providing measures
of in- and post-hospital mortality using administrative
health data [18, 19]. This project led to the develop-
ment of a French version of the hospital standardized
mortality ratio (HSMR) [19] based on 2009 civil year
data (1st January to 31st December). These data were
obtained by individual linkage of two nation-wide data-
bases including the national hospital discharge database
for acute care hospitals (PMSI-MCO) and the national
health insurance claims database (SNIIR-AM). PMSI-
MCO contains medical and administrative information
on all hospital stays for all acute care hospital categories
(i.e. public, private for profit, private non-profit hospitals).
In particular, it also includes length of stay, provenance,
discharge destination, main diagnosis, secondary diagno-
ses (coded according to the 10th revision of the inter-
national Classification of Diseases and related health
problems, ICD-10) and procedure codes (coded according
to the French classification for procedures, CCAM).
SNIIR-AM comprises, for the whole French population,
individual information on all ambulatory care services re-
imbursed by the French national health insurance. It also
contains vital status and dates of death for 77% of the
French population insured under the general health insur-
ance scheme in 2009 [26]. PMSI-MCO and SNIIR-AM
have been routinely linked at patient level since 2007.
Consequently, it was possible to count deaths at specific
timeframes after admission (30, 60 and 90 days post-
admission (dpa)).
HSMRs were calculated with an updated method de-
veloped in the UK by the Dr. Foster Unit at Imperial
College London [20, 27]. This methodology was adapted
notably to cover 100% stays [28]. The main diagnoses
were assigned to the clinical classification system (CCS)
categories (http://www.hcup-us.ahrq.gov/toolssoftware/
ccs/ccs.jsp). For each hospital, its expected number of
deaths was considered as the sum of predicted risks of
death over all stays. The latter was obtained by logistic re-
gression for each CCS or group of CCSs (for CCSs within
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the lower quintile of mortality risk) adjusted for available
case-mix factors. The factors included were: age (frac-
tional polynomial [29]), deprivation [30], sex, Charlson
comorbidity index [31] based on secondary diagnoses
(recalibrated on French data [27]), an interaction term
between Charlson index and age, month of admission,
source of admission and subcategory diagnostic group.
The full description and specificities of our methodology
can be found elsewhere [19].
The whole process was repeated for each selected
timeframe (30, 60 and 90 dpa) and for each HPI (specific
HSMR). Indeed, for each HPI, hospital stays partici-
pating in the related HSMR estimation were selected
according to the defined inclusion and exclusion cri-
teria of the HPI denominator [see Additional file 1].
Given that some hospitals did not have any surgery
department or cancer treatment unit or did not deliver
acute myocardial infarction treatment, numbers of
hospitals involved in HPI calculation were different
across HPIs. Hospitals finally involved in this analysis
were restricted to those having the same identification
number (FINESS number) for process and outcome
measures.
Statistical analysis
Assessing the association between HPIs and specific
HSMRs requires in-depth knowledge about their dis-
tribution. The HSMR numerator, namely the observed
number of deaths, was assumed to follow a Poisson
distribution. Given that mortality is commonly used as
an ultimate outcome, HSMRs were chosen as the
dependent variable. A Poisson model was thus built
with HPIs as the explanatory variables. The convenient
but relatively small sample sizes to estimate HPIs
introduce measurement errors [32].
Several methods enable to correct this error under
certain hypotheses [32]. One of these, the simulation ex-
trapolation method (SIMEX), was applied to correct for
measurement error in HPI estimation, under the hy-
pothesis of a classical additive error [32]. Thus, for each
specific HSMR, we considered log-linear regression
model of Y (i.e. HSMR) on X (HPI) where predictor X
cannot be observed as it is affected by a measurement
error. Assuming that the measurement error is additive
means that instead of X, we observe W = X + U where
U ~ Normal (0, σ2u). In addition, we assume that U is
independent of X and Y. Consequently, if U equals 0,
there is no error in the measurement of X [33]. SIMEX
simulates contaminated datasets (i.e. datasets of W
values with increasingly larger amounts of measurement
errors) in order to study the effect of measurement error
on the fitted coefficients. A corrected coefficient is then
extrapolated from the simulated ones and its precision is
estimated using asymptotic or re-sampling methods.
The full description of this method can be found in
Additional file 2 in supplementary materials.
Secondary analyses were performed to evidence cor-
relations between HSMRs and HPIs without correcting
for measurement error. We used weighted Pearson
correlation tests when HPIs were likely to follow a
normal distribution. When this was not the case, a
Spearman correlation test was conducted. The signifi-
cance level for the entire tests was 0.05 in bilateral for-
mulation. Adjustment for the first type risk error was
not considered due to the exploratory purpose of this
study [34].
The analyses were conducted with SAS® software ex-
cept for the SIMEX method which was performed using
R version 3.1.1 with the SIMEX package (version 1.5).
Results
HSMRs were calculated for 1284 hospitals located in
France based on the 2009 acute care discharge data-
base (PMSI-MCO) which comprised 11,526,545 stays
(Table 1). HSMR medians were close to 1 and the
inter-quartile range decreased for longer timeframes
which means that observed and expected mortality
tends to be similar as the time since admission in-
creases. The lowest median of the HSMR based on the
HPI2 denominator population was the furthest from 1
(from 0.30 for 30 dpa to 0.72 for 90 dpa) and was esti-
mated on the smallest number of hospitals (304).
HPI results and numbers of hospitals evaluated using
HPI’s in 2009 are described in Table 2. Standard devia-
tions and inter-quartile ranges were large compared to
means and medians, somewhat reflecting the between-
hospital variation. For example, the HPI3 mean was
37.70 and its standard deviation was 31.93.
The results of Poisson models corrected with the
SIMEX method are presented in Table 3. HPI4 was
negatively associated with the short timeframe 30 dpa
HSMR (0.72 [0.52–0.99]) but not with 60 dpa or 90 dpa
HSMRs. This means that there was a 28% reduction in
30 dpa HSMR for an HPI4 score changing from 0 to 1
(0 to 100 for percentage). HPI1 was negatively associated
with all HSMRs: 30 dpa HSMR (0.71 [0.54–0.95]), 60
dpa HSMR (0.51 [0.39–0.67]) and 90 dpa HSMR (0.52
[0.40–0.68]). HPI2, HPI3 and HPI5 were not associated
with any HSMR whatever the timeframe.
When testing correlations between HSMRs and HPIs
without correcting for measurement error, we evidenced
that HPI1 was inversely associated with the three
HSMRs: −0.19 (30 dpa HSMR), −0.24 (60 dpa HSMR)
and −0.26 (90 dpa HSMR) (Table 4). Unlike analyses
using the SIMEX approach, HPI3 was inversely associ-
ated with the three HSMRs: 30 dpa HSMR (−0.12), 60
dpa HSMR (−0.15) and 90 dpa HSMR (−0.15).
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Furthermore, HPI4 was inversely associated with the
HSMRs: 30 dpa HSMR (−0.07), 60 dpa HSMR (−0.07)
and 90 dpa HSMR (−0.08).
Discussion
This study showed significant associations between
HSMRs and some HPIs, which strengthens the idea that
low hospital mortality may be associated with high-level
of process indicators. Indeed, HPI1 was negatively asso-
ciated with all HSMRs: 30 dpa HSMR (0.71 [0.54–0.95]),
60 dpa HSMR (0.51 [0.39–0.67]) and 90 dpa HSMR
(0.52 [0.40–0.68]). Also, HPI4 was negatively associated
with 30 dpa HSMR (0.72 [0.52–0.99]). This result is at
the limit of statistical significance, but anesthetic record
contributes to the sharing of information between differ-
ent physicians involved in every step of the anesthetic
management. This information is thus a necessary elem-
ent in the coordination of care and contributes to the
control of the anesthetic risk. Nevertheless, several asso-
ciations were not statistically significant, particularly for
BASI score (HPI2), MDT meetings in oncology (HPI3)
and completeness and quality of medical records (HPI5).
The limited number of significant and expected associa-
tions obtained after the corrections of measurement
errors is consistent with the results of a systematic re-
view published by Pitches et al. [17]. Considering this
lack of associations among extended number of condi-
tions studied, the public reporting of health care
quality indicators may be questionable. Indeed, the risk
of institutional stigma drove by such indicators should
be avoided [35].
Strengths of the study
The main strength of our study is the methodological
approach developed to assess the association between
HSMRs and HPIs. To our knowledge, this is the first
time that a method correcting for measurement error
has been used to improve the accuracy of association
estimates between outcome and process indicators. To
underline this, secondary analyses performed without
any corrections of HPI measurement error revealed
eight supplementary associations (HPI3 and HPI4).
While these associations seem interesting and concep-
tually conceivable, the lack of correction in HPI
measurement error means that no conclusions should
be drawn. Therefore, we recommend using measure-
ment error correction methods, as it is more adapted to
the present design, and it critically impacts the results.
There is still a debate about the suitable timeframes
[36, 37] to assess quality of care using mortality indica-
tors. Several authors suggest selecting specific time-
frames for specific diseases. In the absence of a gold
standard, we decided to select several post-admission
timeframes (from 30 days to 90 days).
Another strength of our study is the broad range of
diseases and care settings considered. Unlike other
studies focusing on a single condition such as myocar-
dial infarction [14, 38], heart failure [15, 16] and acute
coronary syndrome [39], the indicators used are related
to several diseases (e.g. myocardial infarction, cancer),
settings (e.g. medical or surgical units), and to hospital
care management in general.
Finally, the same inclusion and exclusion criteria were
applied to select the medical records involved in the
Table 1 Distributions of Hospital Standardized Mortality Ratios for the five inpatient populations included in HPIs’ denominators
HSMRs Global
(N = 1284)
Specific to HPI1
(N = 1064)
Specific to HPI2
(N = 304)
Specific to HPI3
(N = 730)
Specific to HPI4
(N = 949)
Specific to HPI5
(N = 1068)
Median IQR Median IQR Median IQR Median IQR Median IQR Median IQR
30 dpa 0.94 [0.83–1.13] 1.00 [0.90–1.16] 0.30 [0.00–1.29] 0.91 [0.74–1.10] 1.01 [0.88–1.17] 0.97 [0.87–1.09]
60 dpa 0.96 [0.86–1.10] 0.97 [0.89–1.10] 0.62 [0.00–1.19] 0.94 [0.81–1.08] 0.99 [0.86–1.12] 0.97 [0.90–1.09]
90 dpa 0.97 [0.89–1.09] 0.98 [0.90–1.08] 0.72 [0.25–1.17] 0.96 [0.83–1.08] 1.00 [0.87–1.10] 0.97 [0.90–1.08]
HPI Hospital Process indicators, HPI 1 Nutritional Disorders, HPI 2 Beta-blockers. Antiplatelet agent. Statin and ace Inhibitor, HPI 3 Multidisciplinary Team Meetings
in management, HPI 4 Completeness and Quality for Anesthetic Records, HPI 5 Completeness and Quality of Medical Reports contents, HSMR Hospital Standardized
Mortality Ratio, dpa day post admission
Table 2 Description of Hospital Process Indicators
Name of HPI Number of hospitals Mean STD Coefficient of variation Median IQR
HPI1 1064 74.86 21.00 0.28 80.00 [62.5–92.5]
HPI2 304 70.82 20.42 0.29 73.51 [59.41–86.66]
HPI3 730 37.70 31.93 0.85 36.67 [3.33–66.00]
HPI4 949 75.04 13.18 0.18 75.67 [66.51–84.36]
HPI5 1068 69.84 11.38 0.16 69.39 [62.11–77.02]
HPI Hospital Process indicators, HPI 1 Nutritional Disorders, HPI 2 Beta-blockers. Antiplatelet agent. Statin and ace Inhibitor, HPI 3 Multidisciplinary Team Meetings
in management, HPI 4 Completeness and Quality for Anesthetic Records, HPI 5 Completeness and Quality of Medical Reports contents, HSMR Hospital Standardized
Mortality Ratio, STD standard error, IQR inter-quartile interval
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calculation of process and outcome indicators, thereby
avoiding paradoxical relationships (better process of care
associated with higher mortality ratio). Indeed, Pitches
et al., stressed that such relationships may be susceptible
to ecological fallacy. Indeed, mortality indicators are
sometimes measured for entire hospitals while process
indicators focus on specific sub-groups of patients
within those hospitals. [17].
Limitations of the study
If a unique dimension of quality of care was consistently
assessed both by HPIs and HSMRs, then hospital with
high HPIs should have lower HSMRs. The small number
of associations in our results raised some concerns about
the potential limitations of both HSMRs and HPIs.
The reliability and validity of HSMRs based on French
data are not devoid of criticism. Firstly, administrative
health data used to measure HSMRs may lead to biased
estimations due to the use of different codification
strategies across hospitals [20, 40]. Such biases were re-
ported in 2009 by the French Technical Agency of
Hospital Information which is especially responsible for
the nation-wide collection of hospital discharge data
[40]. The improvement in coding rules and the
amplification of control procedures by the national
health insurance could progressively mitigate these
biases. Moreover, despite important changes in coding
rules and in the definition of main diagnosis in March
2009, these changes did not greatly affect Charlson index
and HSMR calculations [19].
Secondly, according to Dr. Foster Unit’s recommenda-
tions, HSMRs were built sequentially: the same data
were iteratively used to estimate individual Charlson in-
dexes and HSMRs that are adjusted on Charlson index.
It would now be interesting to assess the contribution of
an optimal integrated approach to estimate expected
mortality and assess the potential modification in the as-
sociation between HPI and mortality outcomes. Thirdly,
the lack of adjustment [41] on important predictors
such as the severity of the main condition at admission
(information not recorded) in the calculation of HSMRs
may have weakened their estimations [13, 42]. Inevit-
ably, the limited number of associations in our findings
also raised the question of using other outcomes indica-
tors (e.g. Patient safety indicators) [13]. The prevent-
able deaths when necessary data are collected can also
be considered as an alternative outcome for quality of
care [43, 44].
For HPIs, firstly, the choice for the number of audited
medical records (60 or 80 medical records per hospital)
results from a compromise between accuracy of indica-
tors and acceptability regarding the workload of data
collection for hospitals. Even though the accuracy ob-
tained is adequate for intended uses of HPIs, the small
sample size still induce substantial measurement errors
in the context of this study [25].
Secondly, process indicators are based on laws and
guidelines. Although guidelines are « evidence based »,
they do not rely on randomized controlled trials that
would demonstrate a causal association between care
processes selected as performance measures and mor-
tality measures [45]. Thirdly, inconclusive associations
between quality measures on health care processes and
mortality could also be explained by non-hospital care-
related factors (e.g. socioeconomic context, local health-
care organization) which would affect health outcomes
after discharge. These factors (being out of the hospital
control will impact the HSMR solely, especially if there is
no follow-up after discharge [46]. Furthermore, process
indicators are based on traceability of information col-
lected in medical records and may not accurately reflect
care delivery [21].
Information recorded in databases for both estimating
HSMRs and additional HPIs improved continuously over
the past years. Indeed, information is now more accur-
ate, more variables are recorded, and new indicators (e.g.
assessing the quality of stroke care or hemodialysis) are
under development. These improvements would certainly
Table 3 Associations between HPIs and HSMRs (using SIMEX
method)
HPI HSMR
30 dpa 60 dpa 90 dpa
RR IC RR IC RR IC
HPI1 0.71 [0.54; 0.95]* 0.51 [0.39; 0.67]* 0.52 [0.40; 0.68]*
HPI2 3.9 [0.83; 18.30] 3.17 [0.90; 11.13] 1.31 [0.35; 4.85]
HPI3 0.93 [0.70; 1.24] 1.02 [0.74; 1.39] 0.93 [0.76; 1.13]
HPI4 0.72 [0.52; 0.99]* 0.83 [0.61; 1.13] 0.86 [0.67; 1.11]
HPI5 0.88 [0.69; 1.12] 0.9 [0.73; 1.11] 0.88 [0.73; 1.07]
HPI: Hospital Process indicators; HPI 1: Nutritional Disorders; HPI 2: Beta-blockers.
Antiplatelet agent. Statin and ace Inhibitor; HPI 3: Multidisciplinary Team Meetings
in management; HPI 4: Completeness and Quality for Anesthetic Records; HPI 5:
Completeness and Quality of Medical Reports contents; HSMR: Hospital
Standardized Mortality Ratio
*Results with p < 0.05 are significant
Table 4 Correlations between HSMRs and HPIs without
correcting for measurement error
HPI HSMR
30 dpa 60 dpa 90 dpa
Corr p-value Corr p-value Corr p-value
HPI1 −0.19* <.0001 −0.24* < .0001 −0.26* < .0001
HPI2 0.10 0.07 0.1 0.06 0.07 0.22
HPI3 −0.12* 0.001 −0.15* < .0001 −0.15* <.0001
HPI4 −0.07* 0.03 −0.07* 0.02 −0.08* 0.01
HPI5 −0.04 0.18 −0.05 0.11 −0.04 0.18
*Results with p < 0.05 are significant
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provide interesting additional results. Furthermore, the
use of specific causes mortality as well as other methods
of estimations could improve the accuracy of the associ-
ation. For example, the modeling could be based on two-
level hierarchical models (stays and hospital levels).
HSMRs could be used as dependent variables while HPIs
could serve as independent variables adjusted for hospital
characteristics, having then the same value for all stays in
the same hospital.
Conclusion
Given the various dimensions of process quality covered
by HPIs and various timeframes involved in HSMRs, this
study gives a broad view of the association between
process and outcome indicators, especially in French in-
patients. Due to the limited number of associations after
measurement error correction, our findings warn French
policymakers against inappropriate use of both types of
indicators: each indicator must be evaluated suitably for
each use. Given that any type of indicators solely cannot
fully capture the quality of care complexity, comparative
assessment between hospitals, public reporting or regu-
lation should be based on a simultaneous utilization of
the two types of indicators. New HPIs developed re-
cently together with different outcome indicators, such
as preventable death rate, should be assessed to demon-
strate how improved processes contribute to improve
patient outcomes.
Additional files
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